Literature DB >> 22899304

Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.

Dominic Chih-Cheng Voon1, Huajing Wang, Jason Kin Wai Koo, Tu Anh Pham Nguyen, Yit Teng Hor, Yeh-Shiu Chu, Kosei Ito, Hiroshi Fukamachi, Shing Leng Chan, Jean Paul Thiery, Yoshiaki Ito.   

Abstract

The transcription factor RUNX3 functions as a tumor suppressor in the gastrointestinal epithelium, where its loss is an early event in carcinogenesis. While RUNX3 acts concurrently as a mediator of TGF-β signaling and an antagonist of Wnt, the cellular changes that follow its loss and their contribution to tumorigenicity are not fully understood. Here, we report that the loss of Runx3 in gastric epithelial cells results in spontaneous epithelial-mesenchymal transition (EMT). This produces a tumorigenic stem cell-like subpopulation, which remarkably expresses the gastric stem cell marker Lgr5. This phenomenon is due to the compounding effects of the dysregulation of the TGF-β and Wnt pathways. Specifically, Runx3(-/-) p53(-/-) gastric epithelial cells were unexpectedly sensitized for TGF-β-induced EMT, during which the resultant induction of Lgr5 was enhanced by an aberrantly activated Wnt pathway. These data demonstrate a protective role for RUNX3 in safeguarding gastric epithelial cells against aberrant growth factor signaling and the resultant cellular plasticity and stemness.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899304     DOI: 10.1002/stem.1183

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  36 in total

Review 1.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

2.  RUNX3-dependent oxidative epithelial-to-mesenchymal transition in methamphetamine-induced chronic lung injury.

Authors:  Lin Shi; Bing-Yang Liu; Xin Wang; Mei-Jia Zhu; Lei Chen; Ming-Yuan Zhou; Ying-Jian Gu; Lin Cheng; Yun Wang
Journal:  Cell Stress Chaperones       Date:  2020-07-17       Impact factor: 3.667

3.  DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.

Authors:  Ruixia Xie; Xiaoying Wang; Guoqing Qi; Zhiping Wu; Rong Wei; Peirong Li; Dekui Zhang
Journal:  Tumour Biol       Date:  2016-05-14

Review 4.  The RUNX family: developmental regulators in cancer.

Authors:  Yoshiaki Ito; Suk-Chul Bae; Linda Shyue Huey Chuang
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

Review 5.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

Review 6.  Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma.

Authors:  Yuewu Yang; Zhiqiang Ye; Zengcheng Zou; Gemin Xiao; Gangjian Luo; Hongzhi Yang
Journal:  Tumour Biol       Date:  2014-07-19

7.  RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

Authors:  Y Qiao; S J Lin; Y Chen; D C-C Voon; F Zhu; L S H Chuang; T Wang; P Tan; S C Lee; K G Yeoh; M Sudol; Y Ito
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 8.  Epithelial-mesenchymal transition in gastric cancer.

Authors:  Lei Huang; Ruo-Lin Wu; A-Man Xu
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

9.  Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells.

Authors:  Kee Siang Lim; Zachary Wei Ern Yong; Huajing Wang; Tuan Zea Tan; Ruby Yun-Ju Huang; Daisuke Yamamoto; Noriyuki Inaki; Masaharu Hazawa; Richard W Wong; Hiroko Oshima; Masanobu Oshima; Yoshiaki Ito; Dominic Chih-Cheng Voon
Journal:  J Biol Chem       Date:  2020-03-24       Impact factor: 5.157

10.  Expression of RUNX3 and β-catenin in the carcinogenesis of sporadic colorectal tubular adenoma.

Authors:  Linna Wang; Dan Li; Yang Liu; Yuan Wang; Jinfeng Cui; Airong Cui; Wenxin Wu
Journal:  Tumour Biol       Date:  2014-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.